National Biological Blog Spending on Biologics to double

Companies Vying for Position with Psoriasis Drugs as Industry Sets to Double to Nearly $7 Billion in Next Decade Recently, Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and health care issues, released an article stating that "the continued uptake of marketed and emerging interleukin and TNF-alpha inhibitors and a [...]